A detailed history of Gts Securities LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 80,400 shares of TGTX stock, worth $2.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,400
Previous 119,700 32.83%
Holding current value
$2.59 Million
Previous $2.13 Million 11.7%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$17.21 - $25.28 $463,121 - $680,284
-26,910 Reduced 10.69%
224,875 $5.26 Million
Q2 2024

Aug 14, 2024

BUY
$13.32 - $19.19 $110,209 - $158,778
8,274 Added 3.4%
251,785 $4.48 Million
Q1 2024

May 15, 2024

SELL
$13.02 - $21.3 $2.18 Million - $3.56 Million
-167,260 Reduced 40.72%
243,511 $3.7 Million
Q4 2023

Feb 14, 2024

BUY
$6.68 - $18.81 $1.34 Million - $3.78 Million
200,805 Added 95.64%
410,771 $7.02 Million
Q3 2023

Nov 15, 2023

BUY
$8.36 - $26.5 $1.76 Million - $5.56 Million
209,966 New
209,966 $1.76 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.67B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.